EUVIMEDEUVIMED entdecken
Systematische Übersicht

The role of induction chemotherapy for orbital invasion in sinonasal malignancies: A systematic review

Anthony Tang, Michael Calcaterra, Micah Harris, Paul A Gardner, Georgios A Zenonos, S Tonya Stefko, Mathew Geltzeiler, Dan P Zandberg, Carl H Snyderman iD, Eric W Wang iD, Garret Choby iD

International Forum of Allergy & Rhinology · 2024-07 · 14 (7) · 1226-1239

DOI: 10.1002/alr.23380 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 03.06.2024. Verfasst von Anthony Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms, Induction Chemotherapy, Orbital Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sinonasal malignancies (SNMs) frequently present with orbital invasion. Orbital exenteration (OE) can lead to significant morbidity. Induction chemotherapy (IC) is a promising treatment alternative that may allow for orbit preserving (OP) treatments without compromising patient survival. This systematic review was conducted to synthesize the published data on SNM patients with orbital invasion who underwent IC, including tumor response, orbital outcomes, and survival.

Methods

The study protocol was designed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis guidelines. Databases Embase, Cochrane, Medline, and Scopus, from inception to July 17, 2023, were searched.

Results

Nineteen studies were included, encompassing 305 SNM patients with orbital invasion treated with IC. Fourteen studies reported an overall IC response rate (positive response defined as complete or partial tumor volume reduction) of 77.2%. Among included studies, OE rates after IC ranged from 0 to 40%. Three studies reported a high rate of posttreatment functional orbital preservation (89.8–96.0%). Five studies specifically reported that 62.5% (60 out of 96) of patients were downgraded from planned OE to OP treatment following IC. Three studies reported a significant overall survival (OS) improvement in IC responders versus IC nonresponders. Following IC, 5‐year OS ranged from 44.2 to 55.5%. Patients with olfactory neuroblastoma demonstrated the highest IC response rate and lowest OE rate (100 and 0%, respectively) versus those with sinonasal undifferentiated carcinomas (68.4 and 0%) or squamous cell carcinomas (76.7 and 16%).

Conclusions

For select patients, IC may allow for OP in locally advanced SNMs with orbital involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paranasal Sinus NeoplasmsInduction ChemotherapyOrbital NeoplasmsHumansNeoplasm InvasivenessTreatment OutcomeOrbit

Stichwörter der Autor:innen

induction chemotherapyorbital exenterationorbital invasionorbital preservationsinonasal malignancies

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Los Angeles, California, USA.
  • Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.
  • Department of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Carl H Snyderman, Eric W Wang, Garret Choby

Zitieren

APA

Tang, A., Calcaterra, M., Harris, M., Gardner, P. A., Zenonos, G. A., Stefko, S. T., Geltzeiler, M., Zandberg, D. P., Snyderman, C. H., Wang, E. W., & Choby, G. (2024). The role of induction chemotherapy for orbital invasion in sinonasal malignancies: A systematic review. International Forum of Allergy & Rhinology, 14(7), 1226-1239. https://doi.org/10.1002/alr.23380

Vancouver

Tang A, Calcaterra M, Harris M, Gardner PA, Zenonos GA, Stefko ST, et al. The role of induction chemotherapy for orbital invasion in sinonasal malignancies: A systematic review. International Forum of Allergy & Rhinology. 2024;14(7):1226-1239. doi:10.1002/alr.23380

BibTeX
@article{Tang2024,
  author = {Tang, Anthony and Calcaterra, Michael and Harris, Micah and Gardner, Paul A and Zenonos, Georgios A and Stefko, S Tonya and Geltzeiler, Mathew and Zandberg, Dan P and Snyderman, Carl H and Wang, Eric W and Choby, Garret},
  title = {The role of induction chemotherapy for orbital invasion in sinonasal malignancies: A systematic review},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {1226--1239},
  doi = {10.1002/alr.23380}
}
Kostenlos starten →